Consumer Goods » Food, Beverages & Tobacco | Mega Lifesciences PCL

Mega Lifesciences PCL | Balance Sheet

Fiscal year is January-December. All values THB Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,540
774
1,467
1,234
1,175
930
Total Accounts Receivable
1,824
2,249
2,329
2,303
2,638
2,666
Inventories
1,787
1,769
2,216
2,080
2,427
2,822
Other Current Assets
74
48
157
72
231
51
Total Current Assets
5,225
4,841
6,169
5,689
6,470
6,469
Net Property, Plant & Equipment
970
980
1,031
1,152
1,183
1,426
Total Investments and Advances
11
507
-
5
44
496
Intangible Assets
213
230
233
736
734
1,019
Other Assets
38
71
73
271
186
149
Total Assets
6,536
6,722
7,849
7,941
8,720
9,633
ST Debt & Current Portion LT Debt
785
430
634
663
512
Accounts Payable
1,145
1,404
1,604
1,519
1,598
Income Tax Payable
53
55
80
70
143
Other Current Liabilities
565
622
777
901
1,113
Total Current Liabilities
2,547
2,511
3,095
3,153
3,366
Long-Term Debt
212
137
84
7
-
Provision for Risks & Charges
79
90
94
91
101
Deferred Taxes
76
91
104
87
102
Other Liabilities
2
2
3
10
7
Total Liabilities
2,843
2,744
3,514
3,261
3,475
Common Equity (Total)
3,693
3,978
4,335
4,680
5,244
Total Shareholders' Equity
3,693
3,978
4,335
4,680
5,244
Total Equity
3,693
3,978
4,335
4,680
5,244
Liabilities & Shareholders' Equity
6,536
6,722
7,849
7,941
8,720
Accumulated Minority Interest
-
-
-
-
-

About Mega Lifesciences

View Profile
Address
No. 120, Moo 11, Ample Tower
Bangkok BM 10260
Thailand
Employees -
Website http://www.megawecare.com
Updated 07/08/2019
Mega Lifesciences Public Co. Ltd. engages in the manufacture, market, sale, and distribution of pharmaceutical, nutraceutical products, and consumer goods. It operates through the following segments: Brands; Distribution; and Original Equipment Manufacture (OEM). The Brands segment manufactures and sells goods.